Clinical Trial Update: Antisecretory Factor in Primary Glioblastoma 1 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating antisecretory factor for glioblastoma and associated cerebral edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Edema
• Glioblastoma

Drugs mentioned

• Antisecretory Factor (antisecretory factor)

Snippet

Sponsor: Peter Siesjö | Conditions: Glioblastoma, Cerebral Edema | Phase 1, Phase 2 | Status: COMPLETED